Overview
- Canopy Growth shares surged Friday, climbing about 24% initially and reaching gains of roughly 37% intraday, according to the latest trading snapshots.
- Sector peers also rallied, with cannabis stocks across the Toronto Stock Exchange and Nasdaq moving higher on the policy headlines.
- Benzinga cited reporting from the Washington Post that Trump could instruct agencies to move marijuana to Schedule III, with Axios indicating the shift could come early next year.
- The stock was recently quoted near C$1.57, implying a market capitalization of about C$537 million, according to the coverage.
- Canopy Growth reported Q2 fiscal 2026 revenue of C$66.68 million and a C$0.01 loss per share that beat expectations, yet shares remain down about 68% over 12 months and no federal policy change has been enacted.